Correlation Between Verve Therapeutics and Elevation Oncology

Can any of the company-specific risk be diversified away by investing in both Verve Therapeutics and Elevation Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verve Therapeutics and Elevation Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Verve Therapeutics and Elevation Oncology, you can compare the effects of market volatilities on Verve Therapeutics and Elevation Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verve Therapeutics with a short position of Elevation Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verve Therapeutics and Elevation Oncology.

Diversification Opportunities for Verve Therapeutics and Elevation Oncology

0.53

Correlation Coefficient

Verve Therapeutics  Elevation Oncology

Very weak diversification

The 3 months correlation between Verve and Elevation is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Verve Therapeutics and Elevation Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevation Oncology and Verve Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verve Therapeutics are associated (or correlated) with Elevation Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevation Oncology has no effect on the direction of Verve Therapeutics i.e., Verve Therapeutics and Elevation Oncology go up and down completely randomly.

Pair Corralation between Verve Therapeutics and Elevation Oncology

Given the investment horizon of 90 days Verve Therapeutics is expected to generate 1.0 times more return on investment than Elevation Oncology. However, Verve Therapeutics is 1.0 times more volatile than Elevation Oncology. It trades about -0.03 of its potential returns per unit of risk. Elevation Oncology is currently generating about -0.06 per unit of risk. If you would invest  670.00  in Verve Therapeutics on August 30, 2024 and sell it today you would lose (92.00) from holding Verve Therapeutics or give up 13.73% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Verve Therapeutics  vs.  Elevation Oncology

Verve Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Verve Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Elevation Oncology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Elevation Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with Verve Therapeutics and Elevation Oncology

The main advantage of trading using opposite Verve Therapeutics and Elevation Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verve Therapeutics position performs unexpectedly, Elevation Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevation Oncology will offset losses from the drop in Elevation Oncology's long position.

The idea behind Verve Therapeutics and Elevation Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.